HDAC9 and Huntington disease: Indeed, broad-spectrum HDAC inhibitors partially rectify the transcriptional dysregulation in HD cell and animal models [17]–[23], enhance the degradation of mHTT by altering the acetylation state of key residues within the protein [24]–[27], and improve cognition through enhancement of learning and memory processes [28], [29].